Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,590.20
+5.40 (0.34%)
Jun 6, 2025, 3:30 PM IST

Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 448.76 billion as of June 6, 2025. Its market cap has increased by 55.98% in one year.

Market Cap
448.76B
Enterprise Value
456.43B
Revenue
134.35B
Ranking
n/a
PE Ratio
42.86
Stock Price
1,590.20

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 448.76B, an increase of 38,945.89%. That is a compound annual growth rate of 28.21%.

History

DateMarket Cap% Change
Jun 5, 2025447.23B-1.51%
Dec 31, 2024454.07B88.44%
Dec 29, 2023240.96B101.33%
Dec 30, 2022119.68B-19.75%
Dec 31, 2021149.14B7.10%
Dec 31, 2020139.25B42.03%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Sun Pharmaceutical Industries 3,994.65B
Divi's Laboratories 1,756.87B
Cipla 1,188.77B
Apollo Hospitals Enterprise 985.64B
Mankind Pharma 973.57B
Zydus Lifesciences 937.31B
Aurobindo Pharma 661.36B
Alkem Laboratories 582.10B
Market Cap Rankings